Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Hecla Mining Company Common Stock (HL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Hecla Mining Company Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.53 (market cap $12.58B), while Hecla Mining Company Common Stock trades at $17.29 (market cap $11.24B). The key difference: Halozyme Therapeutics Inc. Common Stock and Hecla Mining Company Common Stock are close in size by market cap, and Hecla Mining Company Common Stock pays a 0.09% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Hecla Mining Company Common Stock for 1 Days on average.
| HALO | HL | |
|---|---|---|
Market Cap | $12.58B | $11.24B |
Volume | 2,179,278 | 37,227,749 |
Sector | Health | Basic Materials |
52-Week High | $115.22 | $31.81 |
52-Week Low | $61.63 | $11.97 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $10.77B |
Dividend Yield | — | 0.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Hecla Mining Company Common Stock
Hecla Mining is a precious metals producer focused on silver and gold. It operates mines in the United States and Canada.
Read more on HL →
